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a b s t r a c t
Ethnopharmacological relevance: Dilodendron bipinnatum Radlk., Sapindaceae, is popularly known as
‘mulher-pobre’. Its stem bark macerate or decoction is popularly used mainly to treat uterine inﬂamma-
tion and bone fractures. Acute oral and subchronic toxicities of the hydroethanolic extract of Dilodendron
bipinnatum (HEDb) were investigated as well as the classes of phytochemical present in the extract.
Materials and methods: Acute toxicity of HEDb was investigated by hippocratic screening in Swiss mice,
cytotoxicity and potential genotoxic effect were evaluated with micronucleus test in the CHO-k1cells.
Subchronic oral toxicity of HEDb was assessed in Wistar rats with graded doses of HEDb repeatedly
administered for 30 days, in order to evaluate the behavioral changes, weight gain, water and feed
consumption, urine and feces excretion, hematological and biochemical parameters and histopatholo-
gical examinations of vital organs.
Results: In hippocratic screening doses up to 5000 mg/kg p.o. did not cause any changes in female mice,
while signs of reduction in motility, increased respiratory rate and tail erection were observed in male mice
but were all reversed within an hour. In cytotoxicity assay, IC50 was 11871.55 mg/mL in CHO-k1 cells.
Micronucleus test demonstrated that the plant extract is non-genotoxic. In subchronic toxicity studies, minor
change was observed as an increase in the urine output in the last 18 days of treatment with 500 mg/kg of
HEDb, while other parameters remained unchanged. All alterations observed were discrete and minor in
nature and were not accompanied by any relevant clinical signs or any toxicologically signiﬁcant biochemical,
hematological and histopathological changes. Preliminary phytochemical analysis revealed the presence of
aurones, chalcones, coumarins, ﬂavonones, ﬂavononoids, phenols, and saponins.
Conclusion: The results demonstrate high safety proﬁle of HEDb in both experimental animals and cell
models assays. However, there may be risk of hepatotoxicity in the use of the extract at high doses for a
prolonged period.
& 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
The uses of medicinal plants in the prevention and treatment of
diseases probably is rooted in the pre-historic era. The early
humans begin health practices by feeding on certain plants by
survival instinct and/or by observation of animals’ behavior. Thus,
it is believed that they observed the effects of these plants, in
order to relieve their ailments, accumulating empirical knowledge
that has been passed down from generation to generation
(Brandão et al., 2004; Albuquerque and Lucena, 2006).
In its global strategy on traditional, complementary and alter-
native medicine, for the period 2014–2023, WHO stressed its
commitment in encouraging the development of public policies
with the objective of inculcating herbal medicine in national
health system of its member states (WHO, 2013).
In Brazil, trade in medicinal plants, which are not considered
drugs, are regulated by Law 5991 (Brasil, 1973), being allowed in
pharmacies and health food stores, however, it is widespread in
the country, and can be found too easily for sale at food stores, free
markets and stalls of healers.
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Because they are derived from natural sources and have been
used for millennia, medicinal plants and plant derivatives as
herbal drugs, tinctures, extracts, resins and latex, are often
presented as free of side effects. However, evidence on the toxicity
risks associated with a wide variety of such remedies has emerged
in the last few years (Jesus et al., 2012).
Plant preparations which are medically useful should be non
toxic or of very low toxicity towards human cells. Therefore, it is
necessary to carry out toxicity studies on medicinal plants even
though they have been used for decades to determine their
potential toxicity levels.
Dilodendron bipinnatum Radlk. (Sapindaceae), is a medium-
sized tree native to Brazil and present in the Pantanal, the Amazon
rainforest, the Cerrado and Atlantic Forest, as well as in the
countries of South America where there is the Pantanal (Pott and
Pott, 1994; Bieski et al., 2012).
Dilodendron bipinnatum is known by the traditional community
of Nossa Senhora Aparecida do Chumbo District (NSACD), which
inhabits the Pantanal, as ‘mulher-pobre’. And it is reportedly used
as an anti-inﬂammatory, diuretic, stimulant, expectorant, sedative,
vermifuge and in the treatment of dermatitis. The decoction or
maceration of the stem bark is employed in the treatment of
uterine inﬂammation and bone fractures, by taking a cup, 2–3
times daily for 15–30 days. There are no reports of its toxicity by
the traditional community of NSACD upon the use of these
preparations (Bieski et al., 2012).
Very few information is available in the literature concerning
Dilodendron bipinnatum. Santos et al. (2010) reported the anti-
microbial activity of ethanol extract of Dilodendron bipinnatum.
The authors described isolation and structural characterization
of some steroids from its leaves, branches and stems, namely:
β-sitosterol, stigmasterol, campesterol, sistotenone, sitosterol 3-O-
β-D-glucopyranoside and cycloartane triterpenes (cycloeucalenol
and 24-methylenecycloartenol).
Given widespread use in popular medicine of Dilodendron bipin-
natum to combat systemic ailments and coupled with lack of toxi-
cological studies that assessed the safety level of the plant's prepara-
tions as it is used in home remedies. This present study was
conducted to contribute to preclinical toxicological validation of
hydroethanolic extract of Dilodendron bipinnatum, using acute and
subchronic toxicity in vivo and in vitro experimental models.
2. Materials and methods
2.1. Cell culture
For the cytotoxicity assay, Chinese hamster ovary cells
(CHO-k1), acquired from the Cell Bank of the Rio de Janeiro (BCRJ)
was used. After thawing the cells were maintained in modiﬁed
Eagle Dulbecco (DMEM) supplemented with 10% fetal bovine
serum (FBS), penicillin (100 U/mL) and streptomycin (100 μg/
mL), under a temperature at 37 1C in atmosphere of 5% CO2 and
90% humidity. Cell viability was assessed by Trypan blue exclusion
method.
2.2. Animals
Albino mice Mus musculus, Swiss-Webster strain (25–30 g) and
albino rats Rattus norvegicus, Wistar strain (180–200 g) were used
in the in vivo studies. Animals used in this study were provided by
the Central Animal House of the Federal University of Mato Grosso
(UFMT). The animals were kept in an animal room where the
temperature was maintained at 2273 1C under a 12 h light dark
cycle. They were provided with standard laboratory chow (Purina,
Labinas, Goiás, Brazil) and water ad libitum. The protocol for
this study was according to the ethical principles of animal
experimentation. The experiments were approved by the UFMT
Ethics Committee for Animal Research (approval no. 23108.
043016/10–6).
2.3. Plant material
The inner stem bark of Dilodendron bipinnatum (Fig. 1), Sapin-
daceae, was collected in November 2010, on the road linking
Cuiabá to the Poconé municipal (GPS coordinates of S 15156.528
and W 057105.6760). Voucher specimen (no. 39235) was deposited
at the UFMT Herbarium. The choice and collection of the plant was
done following an earlier ethnophamacological studies (Bieski
et al., 2012) that was duely approved by the Ethic Committee of
the Júlio Müller Teaching Hospital (HUJM), under the approval
no.561/CEP/HUJM/8. In order to access the traditional knowledge
associated with genetic resources for research purposes from the
traditional communities, an ethical clearance from the Brazilian
Fig. 1. Images of Dilodendron bipinnatum Radlk. in Nossa Senhora do Livramento Municipal, Mato Grosso, Brazil. a leaves and b. inner stem bark of the stem. Photo: Mahon (2012).
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Ministry of Environment, under the auspices of the Council for
Genetic Heritage Management (CGEN/MMA), was obtained under
no. 247. Collection was done after getting approval from the
regulatory authority (ICMbio no. 14360), since it is not an endan-
gered or plant nearing extinction (MMA/Brasil, 2008).
2.4. Plant extract preparation
One kilogram and eight hundred gram (1.8 kg) of the inner bark
of Dilodendron bipinnatum were collected, cleaned, cut in small
pieces, dried under shade for seven days, and ground in an electric
mill (model TE-625, TECNAL, São Paulo, Brazil). The powdered
material was sieved with mesh of size (5 mm). The dried powder
(200 g) obtained was macerated in 70% hydroethanolic solution
(1:3, w/v) for 7 days, ﬁltered and concentrated in a rotary
evaporator (Marconi MA 120, São Paulo, Brazil) under reduced
pressure of 600 mm Hg at 40 1C. The residual solvent was
eliminated in an oven at 45 1C, for 24 h, obtaining hydroethanolic
extract of Dilodendron bipinnatum (HEDb) (with a yield of 16.02%
w/w), which was stored in amber bottle and kept at 4 1C. At the
time of use, HEDb was dissolved in distilled water to obtain the
desired concentration.
2.5. Preliminary phytochemical screening
Preliminary phytochemical screenings were performed for
presence of phenolics, ﬂavonoids, anthocyanins, anthocyanidins,
tannins, coumarins, triterpenes, alkaloids, saponins and steroids,
and were done in duplicate. The tests were based on chromatic
reactions, precipitation and foaming, according to the methodol-
ogy proposed by Matos (2009).
2.6. Toxicological evaluation
2.6.1. Cytotoxicity studies
CHO-k1 cells, of density 2104 cells per dish were plated on a
96-well microplate-containing medium (growth control) with/
without HEDb with concentration range from 3.125–200 mg/mL.
Doxorubicin (0.0058–58 mg/mL) was used as a positive control.
After incubation for 24 h at 37 1C and 5% CO2, the treatments were
removed and 200 mL of 10% Alamar blue solution was added
(Nakayama et al., 1997). After 5 h, absorbance was measured at
540 nm for oxidized state and 620 nm for reduced state, with
ELISA plate reader (Elx800, Bio-Tek, U.S.A.), and then cell viability
was calculated. Drugs that presented IC50 o50 mg/mL were
considered cytotoxic (Fröelich et al., 2007).
2.6.2. Micronucleus test
The cytokinesis-block micronucleus (MN) assay was performed
according to adapted method of Fenech (2000). CHO-k1 cells at
the fourth passage were plated at a density of 1106 cells/bottle
and incubated overnight at 37 1C, 5% CO2 atmosphere to reach
the semiconﬂuent stage. Then, they were treated with HEDb (13.1,
39.3 and 118 mg/mL). One bottle received only Dulbecco's modiﬁed
eagle medium (DMEM) (Sigma-Aldrich, St. Louis, Missouri, U.S.A.)
while another bottle received doxorubicin (Sigma-Aldrich, St.
Louis, Missouri, U.S.A.) (0.03 mg/mL) as negative and positive
mutagenic controls, respectively. After 24 h of treatment, the cells
were treated with 4.5 mg/mL of cytochalasin B (Sigma-Aldrich,
St. Louis, Missouri, U.S.A.), a cytokinesis blocker drug. After 24 h of
incubation at the same conditions, the micronucleus test was
performed.
After trypsinization, the cells were centrifuged, the supernatant
was discarded, and 5 mL of 1% cold sodium citrate was added to
the cell pellet that was then gently resuspended. After 15 s, 5 mL of
freshly prepared ﬁxative (methanol/acetic acid 3:1) and 4 drops of
formaldehyde were added. The cell suspension was centrifuged for
5 min at 174 g. The supernatant was discarded, and the ﬁxation
process was repeated two more times, without formaldehyde.
After the third ﬁxation, about 1 mL of the supernatant was
retained to permit resuspension of the cells. The cell suspension
was dripped onto clean glass slides that had previously been
frozen to dry. Then, the suspension was ﬁxed with methanol and
stained with Giemsa (1:20 in phosphate buffer) for 4 min.
One thousand binucleated cells per slide were analyzed, with
intact nuclei of equal size, similar pattern of staining cytoplasm,
intact membrane, and distinguishable from adjacent cells, exclud-
ing apoptotic and necrotic cells. We considered the micronuclei
that had the same morphology and color of the main nuclei, with
between 1/16 to 1/3 the main nuclei diameter, unrefringent and
not overlapping or connected to the main nuclei. The presence of
buds and dicentric bridges (PNP) in the binucleated cells was
analyzed. To evaluate the frequency, MN/1000 binucleated cells
(including PNP and buds) was used. Nuclear division index (NDI)
was calculated by:
NDI¼ ½ð1mononuclear cellsÞþð2 binuclear cellsÞ
þð3multinuclear cellsÞ=N;
where N¼ total cells number.
2.6.3. Hippocratic screening test
The effect of HEDb on the general behavior of conscious
animals was evaluated in mice, as described by Malone and
Robichaud (1962) with slight modiﬁcation. Brieﬂy, Male and
female mice (n¼5/group) received HEDb (p.o.) at doses of 500,
1000, 3000 and 5000 mg/kg b.w. One control animal per group,
received the vehicle (distilled water, 10 mL/kg). Animals were
observed individually in open ﬁeld at 5, 10, 15, 30, 60, 120 and
240 min and once a day, for a period of fourteen days, noting any
clinical signs or mortality if any, according to established criteria
by Malone and Robichaud (1962).
2.6.4. Subchronic toxicity studies
Subchronic toxicity was evaluated as proposed by Chan et al.
(1982). Animals (n¼6/group) were treated daily by oral gavage
with the vehicle (distilled water, 1 mL/100 g) and HEDb (100 and
500 mg/kg b.w.) for thirty days. Animals were kept in metabolic
cages (model 41800, Ugo Basile, Italy), Body weight and intake of
food and water were determined every 3 days and grouped every
6 days (D1, D2, D3, D4 and D5) over the 30 days. Signs and
symptoms of behavioral alterations were recorded, including skin,
eyes, gastrointestinal, respiratory, central nervous system and
peripheral alterations, including any other general changes. At
the end of the treatments, animals were anesthetized with ethyl
ether and blood collected via vena cava for biochemical and
hematological analyses. Animals were then sacriﬁced by cervical
dislocation, the organs (liver, heart, lung, kidneys, stomach and
spleen) were removed, and relative weights were calculated
(weight of the organ/body weight 100) and were subjected to
a complete necropsy, including external body macroscopic exam-
inations. The organs were ﬁxed in 10% formol solution for
histological analysis.
2.6.5. Hematological analyses
Blood samples were collected in Vacutainers tubes contain-
ing EDTA and hematological tests, including hematocrit (Ht),
hemoglobin (Hb), total platelets, erythrocytes, total leukocytes,
neutrophils, lymphocytes, monocytes, eosinophils, and basophils
were performed with an automatic cell counter (Cell Dyn 3700,
Abott Laboratories, Minnesota, U.S.A.).
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2.6.6. Biochemical analyses
For biochemical analysis, blood without additive was centri-
fuged at 3000  g at 4 1C for 10 min. Serum was separated and
stored at 20 1C until use. Biochemical parameters which are
glucose, creatinine, urea, aspartate aminotransferase (AST), alanine
aminotransferase (ALT), and alkaline phosphatase (AP) were
determined by colorimetric assays with Labtests kits (Minas
Gerais, Brazil).
2.6.7. Histological analyses
Organ samples from each animal were further processed for
histopathology. Samples were routinely processed and sectioned
at 5 μm, stained by hematoxylin and eosin technique (Prophet et al.,
1992) and analyzed under light optical microscope. Vital organs
such as liver, kidneys and lungs were preserved for histopatholo-
gical analysis. The organs were ﬁxed in 10% formalin, dehydrated
in ethanol and clariﬁed in xylene. After processing, the tissues
were embedded in parafﬁn and then sectioned to a thickness
of 5 μm using a Hyrax M60 (Carl Zeiss MicroImaging GmbH,
Germany).The sections were stained with hematoxylin and eosin.
The tissues were examined under a microscope in a random order
and without the knowledge of animal or group. The renal injury
was based on degeneration of Bowman space and glomeruli,
degeneration of proximal and distal tubules, vascular congestion
and interstitial edema. The criteria for liver injury were vacuoliza-
tion of hepatocytes and pyknotic hepatocyte nuclei, number of
Kupffer cells and enlargement of sinusoids. Moreover, the histo-
pathological change of lungs was based on congestion, edema,
inﬂammation and hemorrhage.
2.7. Analyzes of data
Results of parametric tests were expressed in terms of
mean7S.E.M. In the assays involving comparison of more than
two means, one-way ANOVA was used, followed by the Student-
Newman-Keuls test when statistical difference was detected
among the groups. Values of po0.05 were considered signiﬁcant.
The determination of IC50 was made from a linear regression
relating the percentage of inhibition versus the logarithm of the
concentrations tested and using conﬁdence interval of 99%
(po0.01) for the straight line obtained. For in vitro assays not
involving statistical analysis, we used the mean7S.E.M. of three
independent experiments performed in duplicates.
3. Results
3.1. Preliminary phytochemical analysis
Phytochemical analysis of HEDb revealed the presence of
phenolic compounds, chalcones, aurones, ﬂavonones, ﬂavanols,
saponins and coumarins.
3.2. Cytotoxicity in CHO-k1 cells
Treatment with HEDb did not alter the cellular viability of CHO-
k1 cell lines using Alamar blue method at concentrations ranging
from 3.125 to 200 mg/mL. However, reductions in cellular viability
were observed at concentrations above 100 mg/mL. IC50 for HEDb
was 118.071.55 mg/mL. Doxorubicin, the positive control, as
expected was highly cytotoxic with IC50 of 0.370.04 mg/mL.
3.3. Micronucleus test
Table 1 shows the absolute values of MN, PNP, and BUD
aberrations, and nuclear division index (NDI), obtained for the
vehicle, C (13.2, 39.3, and 118.0 mg/mL), and doxorubicin (0.03 mg/
mL). As expected, doxorubicin produced signiﬁcant chromosomal
aberrations in the CHO-k1 cells. However, treatment of the cells
with HEDb showed that the extract is non-genotoxic.
3.4. Hippocratic screening
Administration of HEDb at doses up to 2500 mg/kg p.o.
did not result in any behavioral changes in the male mice. With
5000 mg/kg p.o., there was slight increase in the motility and
respiratory rate in the male mice. These effects began at 15 min
after administration and ceased within 1 h. Oral treatment of the
female mice at doses up to 5000 mg/kg p.o. of HEDb did not cause
any behavioral changes. Moreover, none of the doses led to the
death of any of the mice of both sexes (data not shown). The LD50
therefore could not be determined.
3.5. Subchronic toxicity
Treatments of rats with HEDb at doses of 100 and 500 mg/kg
caused no signiﬁcant changes in the following parameters eval-
uated: body weight and body weight gain, food intake and fecal
excretion throughout the study period when compared to the
vehicle group (Table 2).
At the 500 mg/kg of HEDb, there was a signiﬁcant increases in
urinary excretion which was not time dependent by 15.5%
(po0.01), 13.1% (po0.001) and 24.8% (po0.001) at the 18th
(D3), 24th (D4) and 30th (D5) days respectively, compared to the
vehicle group.
3.5.1. Hematological, relative organ weights and
histopathological analyses
Subchronic oral treatments with HEDb at doses of 100 and
500 mg/kg caused no signiﬁcant changes in the hematological and
visceral relative weights compared to animals in the vehicle group
(data not shown).
Histological analyses of vital organs showed no apparent
alterations in animals that received HEDb (500 mg/kg) compared
to the negative control (vehicle) group, except the presence of
chronic inﬂammation (BALT hyperplasia) in the lungs, both in the
treated animals and in the vehicle treated group.
3.5.2. Biochemical analysis
Subchronic administration of HEDb at a dose of 100 mg/kg
caused no signiﬁcant alterations in the biochemical parameters,
whereas, HEDb at 500 mg/kg resulted in the increases in the AST
and ALT parameters by about 19% (po0.05) in both cases (Table 3).
Table 1
Averages for aberrations in Chinese hamster ovary cells (CHO-k1) treated with
hydroethanolic extract of Dilodendron bipinnatum (HEDb), doxorubicin (Doxo), and
vehicle without treatment.
MNa PNPa BUDa NDI
Vehicle 10.671.6 10.071.8 1.670.8 1.92
HEDb 13.2 mg/mL 24.373.5 11.271.7 3.571.9 1.97
HEDb 39.3 mg/mL 14.773.5 12.271.7 3.071.3 1.85
HEDb 118 mg/mL 29.3713.8 12.771.9 3.070.2 1.88
Doxo 0.03 mg/mL 90.6718.6nnn 37.673.0nnn 30.872.6nnn 1.78
a The aberrations counting was performed in 1000 binucleated cells per slide.
MN: micronuclei; PNP: dicentric bridges; BUD: buds; NDI: nuclear division index.
Results expressed as mean7S.E.M. Kruskal–Wallis test followed by Dunn.
nnn p o 0.001 vs. vehicle.
C.P.C. de Azevedo Neta Mahon et al. / Journal of Ethnopharmacology 155 (2014) 665–671668
4. Discussion
Although herbal medicinal products are widely considered to
be of lower risk compared with synthetic drugs, they are not
completely free from the possibility of toxicity or other adverse
effects (Jordan et al., 2010). Thus, toxicological evaluation of plants
derived products, including extracts forms an essential part of
scientiﬁc validation of medicinal plants.
In order to verify the acute toxicity of HEDb, cytotoxicity assay
and potential genotoxic effects in CHO-k1 cells, while hippocratic
(observational) screening were evaluated in mice.
Alamar blue based cytotoxicity bioassay was used to assess
potential cytotoxic activity of HEDb in CHO-k1 cells. Alamar blue is
a redox indicator that acts across the cell respiratory chain. It is
absorbed by passive diffusion only by viable cells and is reduced in
cytosol by mitochondria, or microsomes (Nakayama et al., 1997).
Based on the IC50 of HEDb, it is considered potentially non-
cytotoxic to CHO-k1 cells (Frӧelich et al., 2007).
Evaluation of DNA damage at the chromosome level is an
essential part of genetic toxicology since mutations in somatic
cells may cause cancer if mutations occur in proto-oncogenes,
tumor suppressor genes and/or DNA damage response genes, and
they are responsible for a variety of genetic diseases (Fenech,
2000; Abdelmigid, 2013). The micronucleus test further attests to
the high safety margin of this extract, as no signiﬁcant chromo-
somal changes were detected in the present study.
Hippocratic test is meant to be a preliminary qualitative
exploration of toxic properties of a substance. This assay also served
as the basis for the establishment of a dosing regimen for subse-
quent pharmacological and toxicological studies (subchronic).
In the oral acute toxicity study, doses up to 2500 mg/kg in mice
did not exhibit no observed adverse effect (NOAEL). Higher doses
Table 2
Effect of the hydroethanolic extract of Dilodendron bipinnatum (HEDb, mg/kg p.o.) on the body weight, accumulated body weight gain, water consumption, fecal and urine
excretion in rats.
Parameters analyzed Period of treatment (days) a
D0 D1 D2 D3 D4 D5
Vehicle
Body weight (g) 181.371.53 193.070.93 211.870.83 229.1710.74 249.970.48 279.973.70
Gain in body weight (g) - 11.770.98 30.571.92 47.871.25 68.670.69 98.671.47
Water consumption (mL) - 52.070.87 52.971.43 54.071.54 49.970.35 45.771.46
Feed consumption (g) - 37.173.44 29.270.89 37.870.97 39.871.05 43.372.74
Fecal excretion (g) - 19.870.90 20.570.78 19.871.48 19.770.67 21.570.64
Urine excretion (mL) - 18.570.42 18.870.47 18.270.47 19.670,51 18.770.42
HEDb 100 mg/kg
Body weight (g) 179.770.58 193.871.39 221.370.87 234.371.90 252.970.95 285.774.20
Gain in body weight (g) - 14.171.36 41.671.69 54.670.87 73.271.56 106.172.14
Water consumption (mL) - 52.370.92 53.871.25 50.970.83 51.170.75 52.170.94
Food consumption (g) - 39.971.26 31.471.50 30.972.64 35.172.24 40.672.50
Fecal excretion (g) - 20.270.98 19.271.24 19.571.19 20.370.85 22.771.09
Urine excretion (mL) - 20.370.88 21.270.47 19.570.22 20.270.79 20.170.57
HEDb 500 mg/kg
Body weight (g) 180.171.34 196.271.47 219.970.63 236.671.02 257.471.79 292.673.57
Gain in body weight (g) - 16.170.36 23.770.97 40.471.53 61.271.65 100.471.98
Water consumption (mL) - 53.371.25 57.671.61 52.171.20 52.171.20 51.870.71
Food consumption (g) - 32.371.34 34.670.90 33.972.35 39.172.82 43.872.59
Fecal excretion (g) - 20.470.68 19.970.94 19.670.99 20.870.85 24.170.33
Urine excretion (mL) - 20.870.88 22.270.60 21.070.63nn 22.270.60nnn 23.370.59nnn
np o 0.05.
a D0 – time zero; D1–D5 – every 6 days; the values represent mean7 S.E.M. for 6 animals/group. One way ANOVA, followed by Student–Newman–Keuls test.
nn po 0.01.
nnn po 0.001 vs vehicle.
Table 3
Effect of subchronic oral administration of the hydroethanolic extract of Dilodendron bipinnatum (HEDb) on biochemical parameters in rats.
Biochemical parametersa HEDb (mg/kg)
Vehicle 100 500
Alkaline phosphatase (U/I) 49.5727.47 40.4773.60 54.5725.22
Total cholesterol (mg/dL) 103.777.93 114.372.40 86.176.19
Creatinine (mg/dL) 0.6070.08 0.4870.04 0.4570.05
Glucose (mg/dL) 214.0722.60 237.2714.50 202.379.45
Protein (g/dL) 5.070.05 5.0870.03 5.0370.03
Aspartate aminotransferase (U/L) 87.874.51 85.874.42 104.776.34 n
Alanine aminotransferase (U/L) 59.373.35 59.177.71 70.374.18n
Triglycerides (mg/dL) 48.674.39 50.876.07 72.0714.09
Urea (mg/dL) 62.072.16 58.872.84 56.773.07
One way ANOVA. followed by Student–Newman–Keuls test.
a The values represent mean7 S.E.M. for 6 animals/group.
n p o 0.05 vs vehicle.
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induced symptoms of mild adverse effects only in the male mice,
but no mortality. The LD50 of HEDb is therefore estimated to
be45000 mg/kg. According to the Hodge and Sterner Scale
(CCOHS, 2005), HEDb may be considered to be non-toxic or at
worst slightly toxic.
Gender discrimination was observed in the acute toxicity test at
higher doses of HEDb. The phenomenon of gender discrimination
with regard to responses to great variety of drugs is common in
in vivo toxicity studies and especially at higher doses (Czerniak,
2001; Sin et al., 2007; Kadekar et al., 2012). The gender discrimi-
nation observed in the mice may include gender-based differences
in the hepatic metabolism (which may be due to differences in
expression of sex-speciﬁc cyctochrome P450s), pharmacokinetics
parameters (plasma clearance and volume) and differences in both
phase I and phase II metabolism.
Although acute behavioral alterations were observed in the
male mice which include moderately increased motility and
respiratory rate and tail erection, these changes were regarded
as toxicologically irrelevant because the adverse effects appeared
only in one sex and/or were not-dose dependent and were
reversible within a short period of time. Moreover, histopatholo-
gical analysis did not reveal any toxicity related changes in any of
the mice (Burn et al., 2006; Mu et al., 2011)
Subchronic toxicity evaluation of substances or plant extracts
by repeated daily dosing for a period of 28 to 30 days is a well
established method, and it is a legal requirement in several
countries.
The body weight gain, water consumption and fecal excretion
were all similar across all the treated groups, and were not
signiﬁcantly different from the vehicle group. With respect to
urine excretion, only the 500 mg/kg/b.w./day differed signiﬁcantly
from the vehicle group. Although, there was a higher urinary
output in the 500 mg/kg treated group, this observation may
relate to the pharmacological use of the extract by the local
populace as a diuretic (Bieski et al., 2012). However, this minimal
increase in the urinary output is not accompanied by any abnor-
mal alterations in the gastrointestinal mucosa, upon macroscopic
as well as microscopic examinations, and thus it is of no toxico-
logical importance (Mu et al., 2011).
The liver plays an important role in the digestion, metabolism,
and storage of nutrients and detoxiﬁcation of xenobiotics. Hepatic
damage may results in increased concentrations of AST, ALT and
AP. The high concentration of serum enzymes such as AST and ALT
is generally regarded as one of the sensitive markers of hepatic
damage (Rodrigues et al., 2010). The full assessment of the liver
enzyme aberration takes into consideration among others, the fold
increase of enzyme activity greater than the normal reference
range (using arbitrary cut-offs, the magnitudes of increased
enzyme activity are considered as mild, o5 times the upper
reference range; moderate, 5–10 times the upper reference range;
or marked, 410 times the upper reference range) (Center, 2007).
Alterations were observed in the values of AST and ALT, in the
500 mg/kg treated group (Table 3). In both cases of the elevations
was not up to one fold (about 20% increases). In addition, the value
encountered for AST is within normal values reported in the
literature (Melo et al., 2013). As noted elsewhere, the reference
range reﬂects the mean value within 2 standard deviations
observed in a “normal” population. Thus, up to 2.5% of normal
individuals can have borderline abnormal enzyme values (Center,
2007). Histopathological evaluations fail to demonstrate any
treatment related changes to the liver of the animals. Put together,
the results demonstrate that the increase in the AST and ALT
enzymes is not treatment related toxicological effects.
Despite the fact injury to liver cells or changes in other
parameters analyzed (hematological, biochemical, feed intake,
water excretion of feces, urine and relative organ weights) were
not observed, there is need to carry out a longer duration
toxicological studies like the type of 3–6 months.
Although, histopathological analysis revealed the presence of
chronic inﬂammation in the lungs of rats (BALT hyperplasia), this
alteration is not treatment related, since similar observation was
noted in the vehicle group. This anomaly may be explained as
follows: ﬁrstly, it may have been due to inhalation of inspired air
by these animals. Secondly, these type of lessions have been
reported to occur spontaneously in rats (Tasaki et al., 2008;
Beserra et al., 2011). And thirdly, there were no alterations in the
relevant biochemical parameters related to kidney function. This
observation is therefore of no toxicological relevance (Wang et al.,
2012).
In this present study, several classes of pharmacological and
biological important phytochemicals were detected in the pre-
liminary screening of HEDb. A number of these classes were
conﬁrmed by HPLC analysis (unpublished data), while some of
which have been subject of attention in in vitro and vivo
toxicological studies (Niho et al., 2001; Locatelli et al., 2008;
Alemany et al., 2014). For example, an excellent review on plant
sterols by Alemany, et al. (2014). A number of studies have noted
that generally pharmacologically active phytoconstituents are
non-toxic at the pharmacological dose and that cytotoxicity or
in vivo toxicities of some of this class of phytochemicals occurred
mainly at higher doses or concentrations, several times above the
pharmacological dose/concentration (Malini and Vanithakumari,
1990; Kritchevsky and Chen, 2005). Although, the levels of each
of these phytochemicals in HEDb were not determined in the
present work, it is unlikely to be of the order that can cause toxic
effect. In addition, the sum effect of the extract could not have
been due to one phytoconstituent, but rather a combination of
each constituent.
In conclusion, the NOAEL in the present study was 500 mg/kg/
day based on all the parameters evaluated and histopathological
changes. Based on body surface area normalization, the human
equivalent dose (HED) is 4864 mg/m2 for a 60 kg adult (Reagan-
Shaw et al., 2007). However, considering the dosage in the popular
medicine; a cup (250 mL) of the decoction is taken 3 times daily
for 20 days in the treatment of rheumatism. For an average person
of 60 kg, an equivalent of 40 mg/kg/day is consumed. Thus, the
HED of the rat dose is 12.5 times more than the average human
daily intake.
5. Conclusion
The present study suggested that the usage of Dilodendron
bipinnatum extract is safe when used in acutely, however caution
should be taken when used in high doses where treatment is to be
prolonged. It is hoped that the results of this study will serve as an
important reference of HEDb for usage as an herbal for humans.
There is need to evaluate the effect of the extract on a longer time
of treatment to deﬁnitely establish the safety of HEDb.
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